| #AWARE.HIV Europe: Supporting Healthcare Professionals to Find Undiagnosed HIV in European Hospi | ohne Phasenangabe | rekrutiert |
| (HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indole | Phase II / Phase III | rekrutiert |
| - IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite S | Phase II | rekrutiert |
| 177Lu-DOTATATE for Recurrent Meningioma | Phase II | rekrutiert |
| 40 Hz Visual Stimulation as an Intervention in Schizophrenia | ohne Phasenangabe | rekrutiert |
| @neurIST : Intregrated Biomedical Informatics for the Management of Cerebral Aneurysms | — | rekrutiert |
| A Clinical Study of Arfolitixorin in Patients With mCRC | Phase I / Phase II | rekrutiert |
| A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK- | Phase III | rekrutiert |
| A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/I | Phase II | rekrutiert |
| A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID- | Phase III | rekrutiert |
| A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK- | Phase III | rekrutiert |
| A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-796 | Phase III | rekrutiert |
| A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-724 | Phase II | rekrutiert |
| A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorub | Phase II | rekrutiert |
| A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients Wi | Phase III | rekrutiert |
| A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed | Phase III | rekrutiert |
| A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially B | Phase I / Phase II | rekrutiert |
| A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Co | Phase II / Phase III | rekrutiert |
| A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease | Phase III | rekrutiert |
| A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease | Phase II | rekrutiert |
| A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world Sett | — | rekrutiert |
| A Comparison of Two Psychotherapy Programs in Persistently Depressed Treatment-Resistant Inpatie | ohne Phasenangabe | rekrutiert |
| A Comparison of the Resection Rate for Hot and Cold Snare Polypectomy of Colorectal Polyps (10-1 | ohne Phasenangabe | rekrutiert |
| A Contrast Medium Sparing Strategy Using Automated CO2 Injection During PVI for Prevention of Ma | Phase III | rekrutiert |
| A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies | Phase I / Phase II | rekrutiert |
| A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patien | Phase III | rekrutiert |
| A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibros | Phase III | rekrutiert |
| A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease | Phase II | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment | Phase III | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Trea | Phase III | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Trea | Phase III | rekrutiert |
| A Global Prospective Observational Registry of Patients With Pompe Disease | — | rekrutiert |
| A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head | Phase III | rekrutiert |
| A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradi | Phase III | rekrutiert |
| A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis | Phase II | rekrutiert |
| A Longitudinal Natural History Study of OPA1-Associated Autosomal-Dominant Optic Atrophy | — | rekrutiert |
| A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulce | Phase III | rekrutiert |
| A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesit | Phase III | rekrutiert |
| A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: D | — | rekrutiert |
| A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on | Phase II | rekrutiert |
| A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Scle | — | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy | Phase I / Phase II | rekrutiert |
| A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1) | Phase I / Phase II | rekrutiert |
| A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases | Phase II | rekrutiert |
| A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Diseas | Phase II | rekrutiert |
| A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOV | Phase II | rekrutiert |
| A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Prev | Phase III | rekrutiert |
| A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treat | Phase III | rekrutiert |
| A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart | Phase III | rekrutiert |
| A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 C | Phase II | rekrutiert |
| A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Even | Phase III | rekrutiert |
| A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Pl | Phase III | rekrutiert |
| A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanc | Phase III | rekrutiert |
| A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With | Phase II | rekrutiert |
| A Phase IIb Study to Evaluate AZD8965 in Participants With IPF. | Phase II | rekrutiert |
| A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab P | Phase I | rekrutiert |
| A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in | Phase I / Phase II | rekrutiert |
| A Phase-3-trial of Acalabrutinib, Obinutuzumab & Venetoclax Compared to Obinutuzumab and Venetoc | Phase III | rekrutiert |
| A Pivotal Study of N-Acetyl-L-Leucine on Niemann-Pick Disease Type C | Phase III | rekrutiert |
| A Platform Study in Non-Small Cell Lung Cancer (NSCLC) | Phase I / Phase II | rekrutiert |
| A Prospective, Bicentric Evaluation of Fluciclovine PET-imaging in Patients with Prior Negative | — | rekrutiert |
| A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severe | Phase III | rekrutiert |
| A Registry Study on HIV-related Lymphoma | — | rekrutiert |
| A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Stu | Phase II | rekrutiert |
| A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD | Phase III | rekrutiert |
| A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination Wit | Phase III | rekrutiert |
| A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa | Phase II / Phase III | rekrutiert |
| A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet | Phase III | rekrutiert |
| A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab a | Phase III | rekrutiert |
| A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Do | Phase III | rekrutiert |
| A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients W | Phase I | rekrutiert |
| A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe | Phase II / Phase III | rekrutiert |
| A Study With CIT-013 in RA Patients | Phase II | rekrutiert |
| A Study in Children and, Adults With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Treat | — | rekrutiert |
| A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell | Phase I / Phase II | rekrutiert |
| A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Ch | Phase III | rekrutiert |
| A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participa | Phase I / Phase II | rekrutiert |
| A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With | Phase III | rekrutiert |
| A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First | Phase III | rekrutiert |
| A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platin | Phase II | rekrutiert |
| A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Adva | Phase II | rekrutiert |
| A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children | Phase III | rekrutiert |
| A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Al | Phase III | rekrutiert |
| A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly D | Phase III | rekrutiert |
| A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagn | Phase III | rekrutiert |
| A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adju | Phase III | rekrutiert |
| A Study of Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter With the TRUPULSE™ Generator for Treat | ohne Phasenangabe | rekrutiert |
| A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies | Phase I / Phase II | rekrutiert |
| A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early | Phase III | rekrutiert |
| A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulce | Phase II | rekrutiert |
| A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastat | Phase III | rekrutiert |
| A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) | Phase III | rekrutiert |
| A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Cro | Phase III | rekrutiert |
| A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) | Phase II | rekrutiert |
| A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated | Phase II / Phase III | rekrutiert |
| A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 | Phase I | rekrutiert |
| A Study of LY4257496 in Participants With Cancer (OMNIRAY) | Phase I | rekrutiert |
| A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Co | Phase II | rekrutiert |
| A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tum | Phase I / Phase II | rekrutiert |
| A Study of Navlimetostat (BMS-986504) in Participants With Pre-treated Advanced or Metastatic No | Phase II | rekrutiert |
| A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus | Phase III | rekrutiert |
| A Study of Obexelimab in Patients With Systemic Lupus Erythematosus | Phase II | rekrutiert |
| A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Meta | Phase III | rekrutiert |
| A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthriti | Phase III | rekrutiert |
| A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cance | Phase III | rekrutiert |
| A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration | Phase III | rekrutiert |
| A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lym | Phase I / Phase II | rekrutiert |
| A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of E | Phase II / Phase III | rekrutiert |
| A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide | Phase I | rekrutiert |
| A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tra | Phase III | rekrutiert |
| A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembroliz | Phase III | rekrutiert |
| A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With | Phase III | rekrutiert |
| A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoP | — | rekrutiert |
| A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease | Phase III | rekrutiert |
| A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-li | Phase III | rekrutiert |
| A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract | Phase III | rekrutiert |
| A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines | Phase III | rekrutiert |
| A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Canc | Phase III | rekrutiert |
| A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of | Phase II / Phase III | rekrutiert |
| A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRI | Phase II | rekrutiert |
| A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia | — | rekrutiert |
| A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in | Phase I / Phase II | rekrutiert |
| A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneo | Phase III | rekrutiert |
| A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult an | Phase III | rekrutiert |
| A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism | Phase III | rekrutiert |
| A Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney | Phase II | rekrutiert |
| A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to | Phase III | rekrutiert |
| A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PA | Phase II | rekrutiert |
| A Study to Assess the Effects of Zigakibart on IgA Nephropathy. | Phase II | rekrutiert |
| A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previous | Phase III | rekrutiert |
| A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Par | Phase II | rekrutiert |
| A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spas | Phase I / Phase II | rekrutiert |
| A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemothe | Phase II / Phase III | rekrutiert |
| A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of The | Phase III | rekrutiert |
| A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Parti | Phase III | rekrutiert |
| A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + | Phase III | rekrutiert |
| A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab P | Phase III | rekrutiert |
| A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia | Phase III | rekrutiert |
| A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-M | Phase III | rekrutiert |
| A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD | Phase III | rekrutiert |
| A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 | Phase III | rekrutiert |
| A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept | Phase III | rekrutiert |
| A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bort | Phase III | rekrutiert |
| A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting | Phase I / Phase II | rekrutiert |
| A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants Wi | Phase III | rekrutiert |
| A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard | Phase II | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demye | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Mo | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Plac | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants Wit | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzhe | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzhe | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sc | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Ol | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab Wit | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moder | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Y | Phase II | rekrutiert |
| A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive | Phase III | rekrutiert |
| A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent | Phase III | rekrutiert |
| A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects | Phase II | rekrutiert |
| A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus | Phase II / Phase III | rekrutiert |
| A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as | Phase II | rekrutiert |
| A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination | Phase I / Phase II | rekrutiert |
| A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïv | Phase III | rekrutiert |
| A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Level | — | rekrutiert |
| A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 | Phase III | rekrutiert |
| A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adul | Phase III | rekrutiert |
| A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotocl | Phase III | rekrutiert |
| A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injec | Phase III | rekrutiert |
| A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Pl | Phase III | rekrutiert |
| A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and S | Phase I | rekrutiert |
| A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Partic | Phase I | rekrutiert |
| A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients Wit | Phase III | rekrutiert |
| A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With | Phase III | rekrutiert |
| A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely | Phase III | rekrutiert |
| A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With | — | rekrutiert |
| A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chron | Phase III | rekrutiert |
| A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Can | Phase I | rekrutiert |
| A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in t | Phase I | rekrutiert |
| A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythemato | Phase II | rekrutiert |
| A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseas | Phase III | rekrutiert |
| A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of | Phase III | rekrutiert |
| A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in P | Phase I / Phase II | rekrutiert |
| A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathi | Phase III | rekrutiert |
| A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rit | Phase III | rekrutiert |
| A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atr | Phase II | rekrutiert |
| ACCESS Registry: A Post Market Follow-up Study to Monitor the Safety, Performance and Usability | — | rekrutiert |
| ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or | Phase I / Phase II | rekrutiert |
| AIO-BNHO Comprehensive Clinico-genomics Database Network - AIO-BNHO CONNECT | — | rekrutiert |
| ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants Wi | Phase II | rekrutiert |
| ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With | Phase III | rekrutiert |
| AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Sol | Phase II | rekrutiert |
| AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer. | ohne Phasenangabe | rekrutiert |
| AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia | Phase I / Phase II | rekrutiert |
| AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate | Phase III | rekrutiert |
| Abbott Structural Heart Device Registry | — | rekrutiert |
| Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL | Phase III | rekrutiert |
| Additional Chemotherapy for EGFRm Patients with the Continued Presence of Plasma CtDNA EGFRm At | Phase II | rekrutiert |
| Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochem | Phase III | rekrutiert |
| AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure | ohne Phasenangabe | rekrutiert |
| AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combinat | Phase II | rekrutiert |
| Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leuka | Phase II / Phase III | rekrutiert |
| Alloplastic Total Temporomandibular Joint (TMJ) Replacement Registry | — | rekrutiert |
| Amino Acid PET-based Response Assessment in IDH-mutant Gliomas (APPEAR) | — | rekrutiert |
| Amyloid-β Clearance Mechanisms in Alzheimer's Disease | — | rekrutiert |
| An Extension Study to Evaluate Safety and Efficacy of Atumelnant in Participants With Congenital | Phase II | rekrutiert |
| An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy | Phase II | rekrutiert |
| An Observational Post-marketing Study Using Commercially Approved Biosense Webster (BWI) Medical | — | rekrutiert |
| An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly | — | rekrutiert |
| An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients | — | rekrutiert |
| An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-ter | Phase III | rekrutiert |
| An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA | Phase III | rekrutiert |
| Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer | ohne Phasenangabe | rekrutiert |
| Anesthesia for Catheter Aortic Valve ImplantATIOn Registry | — | rekrutiert |
| Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection | Phase I / Phase II | rekrutiert |
| Anti-viral Action Against Type 1 Diabetes Autoimmunity | Phase IV | rekrutiert |
| Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG | Phase III | rekrutiert |
| Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Stud | ohne Phasenangabe | rekrutiert |
| Assessing Declined Liver Grafts With Normothermic Machine Perfusion to Reduce Transplant Waiting | ohne Phasenangabe | rekrutiert |
| Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipopr | Phase III | rekrutiert |
| Assessment of Daily Stressors in Children With Depressive Symptoms for the Development of a Gami | — | rekrutiert |
| Assessment of Physical Activity and Cardiovascular Outcomes in Patients With Chronic Heart Failu | — | rekrutiert |
| Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation (ATRIA | — | rekrutiert |
| At-Home tDCS as Maintenance Therapy | ohne Phasenangabe | rekrutiert |
| BIO|CONCEPT.BIOMONITOR-HF Collect Clinical Data From Heart Failure Patients Using BIOMONITOR Dev | ohne Phasenangabe | rekrutiert |
| BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatmen | — | rekrutiert |
| BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF | ohne Phasenangabe | rekrutiert |
| Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With | Phase II | rekrutiert |
| Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreat | Phase II | rekrutiert |
| Better Leukemia Diagnostics Through AI (BELUGA) | — | rekrutiert |
| Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment | — | rekrutiert |
| Blood Flow Restriction Training For The Treatment Of Lateral Epicondylopathy | ohne Phasenangabe | rekrutiert |
| Bone Substitutes Outcomes - Post Market Follow-up | — | rekrutiert |
| CAR-T Long Term Follow Up (LTFU) Study | Phase III | rekrutiert |
| CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma | Phase II | rekrutiert |
| CArdioSurgEry Atrial Fibrillation Register | — | rekrutiert |
| CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry | — | rekrutiert |
| CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitu | Phase III | rekrutiert |
| CLL-IMPACT: A Clinical Nutrition Trial Investigating Immune and Metabolic Changes in Early-Stage | ohne Phasenangabe | rekrutiert |
| COGSCREEN II: Early Detection of Cognitive Impairment | ohne Phasenangabe | rekrutiert |
| COMPERA / COMPERA-KIDS | — | rekrutiert |
| CRS Questionnaire Validation Project | — | rekrutiert |
| CeraFlex PFO Closure System PMCF Study | — | rekrutiert |
| Characterizing the Retinal Microvasculature in Patients with Fabry Disease: a Prospective Observ | — | rekrutiert |
| Clinical Performance and Safety Assessment of the Use of iCover Balloon Expandable Covered Stent | ohne Phasenangabe | rekrutiert |
| Clinical Performance and Safety of the Unicompartmental Univation® XF Pro Implant | — | rekrutiert |
| Clinical Performance of the New Plasma Filter PX2 in TPE Treatments | ohne Phasenangabe | rekrutiert |